| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 3 buys and 36 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.89M | $47.16M | - | |
| Dir | 4.47M | $43.18M | - | |
| Other | 240.0K | $2.32M | - | |
| Other | 240.0K | $2.32M | - | |
| CEO | 240.0K | $2.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $9.28 | $927,735.00 | -2.7% | +1.6% | +43.0% | |
| Mar 27, 2024 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,401,299 | $9.48 | $13,289,410.41 | +5.2% | -23.2% | +26.8% | |
| Mar 25, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 97,610 | $9.12 | $890,322.34 | -1.3% | -9.7% | +44.0% | |
| Mar 25, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 97,610 | $9.12 | $890,322.34 | -1.3% | -9.7% | +44.0% | |
| Mar 21, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 2,390 | $9.03 | $21,572.06 | - | -14.1% | +37.3% | |
| Mar 21, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 2,390 | $9.03 | $21,572.06 | - | -14.1% | +37.3% | |
| Mar 15, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $9.14 | $913,681.28 | -0.9% | -2.4% | +29.6% | |
| Mar 15, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $9.14 | $913,681.28 | -0.9% | -2.4% | +29.6% | |
| Feb 29, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 3,782 | $9.02 | $34,100.58 | - | +5.4% | +25.2% | |
| Feb 29, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 3,782 | $9.02 | $34,100.58 | - | +5.4% | +25.2% |